Photo: Fred Hutch
Education, Training, Board Certifications
- M.D., University of Washington
- Ph.D., University of Washington
- Residency, UW
- Fellowship, UW/Fred Hutch
- Medical Oncology, American Board of Internal Medicine
- Hematology, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Clinical Expertise
- Skin cancer
- Melanoma
- Merkel cell carcinoma
Affiliations
Publications
Research and/or clinical interests
In the laboratory and in clinical trials, Dr. Joshua Veatch develops and tests new immunotherapies for lung cancers and skin cancers. He studies how tumor-recognizing T cells — a type of immune cell — respond to these solid tumors, and how to improve those responses to help patients. One research focus is on CD4, or "helper" T cells, and the roles they play in the larger immune response to tumors. He is developing new therapies in which a patient's helper T cells would be genetically engineered to better fight their cancer. Another focus is on developing therapeutic cancer vaccines, which can boost T-cell responses to tumors. Dr. Veatch is also a medical oncologist who treats people with melanoma, Merkel cell carcinoma and other advanced skin cancers.
